Extract

To collect post marketing surveillance data on patients receiving at least one Combo Bio-Engineered Sirolimus Eluting Stent when used according to the Instructions for Use. Data will be collected in order to assess the long term safety and performance of the Combo Stent in routine clinical practice.

Inclusion criteria

• Coronary (artery) disease,Atherosclerosis

Links

• ictrp
• nct